Skip to main content

Over two million people in England may be eligible for surgery to treat obesity

Over two million people in England may be eligible for surgery to treat obesity, according to new research published in JRSM Open. However, fewer than 7000 patients underwent these procedures in 2011.

Carrying out more bariatric surgery procedures would help to reduce obesity-related ill health, the study authors from Imperial College London said, but the NHS may need to invest in more resources to meet demand.

Bariatric surgery – a set of surgical procedures performed on obese people to decrease their stomach size – can greatly reduce the likelihood of death from obesity-related diseases such as type 2 diabetes, stroke or coronary heart disease.

Despite clear guidelines outlining who can undergo such surgery with the NHS, and evidence that these procedures are cost-effective in the long run, less than one per cent of those eligible have weight loss surgery each year. The researchers say this raises questions about why more procedures are not currently being carried out.

One possible reason is lack of awareness of the surgical procedures and potential benefits. Commitment to lifestyle intervention is also an important barrier, as patients must be willing to enter a full life-changing programme involving intensive management in a specialist obesity service and commitment to long-term follow-up.

Those eligible are more likely to be women, be retired, have no formal education and be from a lower socio-economic status than the general population.

Dr Sonia Saxena, from the Department of Primary Care and Public Health at Imperial College London, said: “Performing more operations could be very good for the population in terms of improving patient health. You could cut down on a number of very severe conditions and extend life expectancy in patients who are likely to suffer significant problems as a result of their obesity.”

But the research, funded by the Higher Education Funding Council for England and the National Institute for Health Research, revealed that the capacity of health services to meet this demand is limited.

The NHS would be overwhelmed because there isn’t the resource to actually carry out this number of operations,” Dr Saxena added.

If everyone who was eligible came forward there would most likely be a restriction because of funding and resource allocation at the local level.”

To calculate the number of eligible people, twe used population data from the 2006 Health Survey for England, a nationally representative household survey carried out every year by the government to plan health services and make policy decisions.

We combined them with guidelines from the 2006 UK National Institute for Health and Clinical Excellence (NICE). The NICE guidelines assess eligibility for bariatric surgery according to a person’s body mass index (BMI), a measure of body shape based on mass and height. People with a BMI exceeding 40, or those with a BMI between 35 and 40 and suffering from one or more obesity-related diseases, are eligible for bariatric surgery with the NHS.

But Dr Saxena explained that eligibility based on NICE guidelines alone is not the end of the story. “We know from our previous work in the United States that fewer bariatric surgery operations are carried out in disadvantaged groups who are most in need of the operation because of a lack of health coverage. But everyone who is eligible is entitled to the operation in the NHS and there is a huge potential health gain. Some of those who are eligible may not be aware they could benefit or willing to make the lifestyle changes for a successful procedure.”

Reference: A. Ahmad et al. 'Eligibility for bariatric surgery among adults in England: analysis of a national cross-sectional survey.' JRSM Open January 2014 vol. 5 no. 1

Media Coverage
Daily Mirror
Daily Express
Daily Mail


Popular posts from this blog

Can GPs issue private prescriptions to NHS patients?

The NHS prescription charge in England is currently £8.60 per item. At this level, many commonly prescribed drugs will cost less than the prescription charge and so some NHS patients may occasionally ask if they can have a private prescription rather than an NHS prescription.

In the past, some GPs have been advised that they could issue both an NHS FP10 and a private prescription, and let the patient decide which to use. But the British Medical Association's General Practice Committee has obtained legal advice that said under the current primary care contract, GPs in England may not issue a private prescription alongside or as an alternative to an NHS FP10 prescription. In any consultation where a GP needs to issue an FP10, the concurrent issue of a private prescription would be a breach of NHS regulations.

The issuing of a private prescription in such circumstances could also be seen as an attempt to deprive the NHS of the funds it would receive from the prescription charge. Fur…

What will Brexit mean for the NHS?

On the 29 March 2017, the Prime Minister of the UK Theresa May, formally notified the European Union (EU) Council President, Donald Tusk, of the UK’s intention to leave the EU. Theresa May’s letter to Donald Tusk triggers a two-year process during which the UK will have to negotiate both the terms of its exit from EU and the arrangements that will replace those we have had for over 40 years with the other member states of the EU. The consequences of the United Kingdom’s departure from the EU (commonly referred to as ‘Brexit’) will be wide-ranging and will affect all areas of UK’s society, including the National Health Service (NHS).

For the NHS, Brexit comes at a time when it faces many other major challenges. These include severe financial pressures, rising workload, increased waiting times for both primary care and specialist services, and shortages of health professionals in many key areas (such as in general practice and in emergency departments). The NHS also faces challenges fr…

Dr Demis Hassabis, Co-Founder and CEO of DeepMind, Speaks about AI in Healthcare

On 28 September 2017, I attended the Annual Institute of Global Health Innovation Lecture: Artificial General Intelligence and Healthcare, delivered by Dr Demis Hassabis, co-founder and CEO of Google DeepMind. Artificial intelligence is the science of making machines smart argued Dr Hassabis, so how can we make it improve the healthcare sector? Dr Hassabis then went on to describe the work that DeepMind was carrying out in healthcare in areas such as organising information, deep learning to support the reporting of medical images (such as scans and pathology slides), and biomedical science. Dr Hassabis also discussed the challenges of applying techniques such as reinforcement learning in healthcare. He concluded that artificial intelligence has great scope for improving healthcare; for example, by prioritising the tasks that clinicians had to carry out and by providing decision support aids for both patients and doctors. Dr Hassabis also discussed some of the ethical issues in using …